How Accurate Is a Positive NIPT for Trisomy 18? Next Steps
At a Glance
A positive NIPT for trisomy 18 indicates increased risk but does not confirm Edwards syndrome. Your personal chance depends on baseline risk, age, ultrasound, and the laboratory; CVS or amniocentesis is needed for diagnostic confirmation before birth.
In this answer
3 sections
Getting a “high-risk” or positive Non-Invasive Prenatal Test (NIPT) result for trisomy 18 (Edwards syndrome) can be frightening and overwhelming. It is important to know that this result is not caused by anything you did, and you do not have to navigate this alone. A positive NIPT means there is an increased chance your baby has the condition, but it is a screening test, not a diagnosis [1].
Because false-positive screens occur, medical guidelines strongly advise against making irreversible pregnancy decisions based solely on an NIPT result [1][2]. Diagnostic testing is the only way to know for certain before birth, though the choice to undergo these procedures is entirely up to you [1][3].
What you can do right now:
- Pause: Do not make any permanent decisions about your pregnancy based only on this screening result [1].
- Connect: Contact your obstetric clinician promptly to request a referral to a genetic counselor or a maternal-fetal medicine specialist (a doctor who specializes in high-risk pregnancies).
- Gather details: Ask your clinic for a copy of the full laboratory report, which includes details like your “fetal fraction” and the specific test used.
Screening vs. Diagnosis
The NIPT (also called cell-free DNA screening) analyzes fragments of DNA from the placenta that circulate in your blood. It is an excellent screening tool because it identifies who is at higher risk, but it cannot definitively diagnose a condition [1].
Sometimes, the genetic makeup of the placenta is different from the baby’s. This is called confined placental mosaicism [4]. When this happens, the NIPT can show a high risk for trisomy 18 even when the baby does not have the condition [5]. Diagnostic tests are offered to resolve this uncertainty.
How Accurate is the NIPT?
When looking at the NIPT’s performance for trisomy 18 in singleton pregnancies, the numbers are strong but not perfect:
- Sensitivity: The test correctly flags about 97.7% of pregnancies where trisomy 18 is actually present [2].
- Specificity: It correctly identifies unaffected pregnancies about 99.9% of the time, meaning the false-positive rate is roughly 0.1% [2].
Because trisomy 18 is a rare condition, even a 0.1% false-positive rate means that many “high-risk” screens turn out to be pregnancies without detected trisomy 18.
Positive Predictive Value (PPV)
To understand your actual chances, doctors look at the Positive Predictive Value (PPV). PPV answers the question: Out of everyone who gets a high-risk result, how many actually have a baby with the condition?
Your personal PPV is not just based on the test; it is heavily influenced by your underlying baseline risk (pretest probability), which factors in your age and ultrasound findings [6][7].
- If baseline risk is low (e.g., 0.1%): Statistical models suggest the PPV is roughly 49%. This means there is about a 51% chance the result is a false-positive screen [2].
- If baseline risk is higher (e.g., 1%): The PPV jumps to roughly 91% [2].
- In real-world studies: A large multicenter study found a PPV of about 35% across its general population, while studies focusing on older patients or higher-risk pregnancies saw PPVs around 67% or higher [8][9].
Your genetic counselor can calculate a personalized PPV for you based on the specific laboratory used, your age, and your medical history.
Next Steps: Ultrasound and Confirmatory Testing
Your specialist team will help you weigh your options. You may choose to pursue diagnostic testing, decline testing, or wait until the baby is born to arrange testing.
Targeted Ultrasound
A detailed ultrasound looks for physical signs or structural differences often seen with trisomy 18. While an ultrasound provides valuable context and can adjust your risk estimate, it cannot confirm or completely rule out the diagnosis on its own [10][11]. Ultrasound should complement, not unnecessarily delay, diagnostic testing.
Diagnostic Testing Options
If you want definitive answers before birth, you will be offered invasive diagnostic testing. There are two primary options depending on the timing of your pregnancy:
Chorionic Villus Sampling (CVS)
- Timing: Usually performed between 10 and 13 weeks of pregnancy [12].
- How it works: A doctor takes a tiny tissue sample from the placenta.
- Limitations: Because CVS samples the placenta (like the NIPT), it can be affected by confined placental mosaicism. In one large dataset, about 4% of high-risk trisomy 18 screens that went to CVS showed “mosaicism” (a mix of typical and atypical cells in the sample) [13]. A mosaic CVS result does not automatically mean the baby is affected, and it usually requires a follow-up amniocentesis to see if the fetus shares those cells [13].
Amniocentesis
- Timing: Typically performed from 15 weeks of pregnancy onward [12][14].
- How it works: A doctor takes a small sample of amniotic fluid, which contains cells shed directly by the baby.
- Advantage: Amniocentesis is considered highly definitive because it bypasses the placenta and looks directly at fetal cells, avoiding the confusion of confined placental mosaicism [15].
Procedure Risks and Safety
Both CVS and amniocentesis carry a small risk of procedure-attributable miscarriage. Large population analyses estimate this added risk at roughly 0.12% to 0.30% for amniocentesis, with similar or slightly different estimates for CVS depending on the study [16].
These are average numbers; your personal risk depends heavily on the specific clinic and the doctor’s experience. Ask your center for their specific complication rates. If you undergo a procedure, you will be monitored and should contact your clinic immediately if you experience heavy bleeding, fluid leakage, fever, or severe abdominal pain [17][18]. If you have an Rh-negative blood type, you will also receive guidance on anti-D (RhoGAM) injections.
Understanding the Results
Diagnostic testing can often provide rapid preliminary results within a few days, followed by a final comprehensive laboratory report (such as a full karyotype or microarray) a week or two later.
If trisomy 18 is confirmed, genetic counseling will focus on your values, your specific results, and your options [3]. While trisomy 18 is a severe condition, an NIPT or ultrasound cannot predict the exact severity or course for an individual baby. You will be supported in discussing pregnancy management options, including continuation of the pregnancy, palliative neonatal care, life-prolonging interventions, or pregnancy termination [19].
Common questions in this guide
How accurate is a positive NIPT result for trisomy 18?
What is the chance that my positive trisomy 18 NIPT is a false positive?
Which test confirms trisomy 18 after a positive NIPT?
When can I have CVS or amniocentesis?
Can an ultrasound confirm or rule out trisomy 18?
What happens if CVS shows mosaicism?
How risky are CVS and amniocentesis?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Would CVS or amniocentesis give a definitive answer, and when are they usually done?
Genetic counseling
Could a genetic counselor help me understand what this screening result means for my pregnancy?
About ultrasound
Could a detailed ultrasound change my estimated risk, and what would it look for?
Related questions
Show more
Get notified when new evidence is published on Trisomy 18 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
Obstetrics and gynecology 2015; (126(3)):e31-e37 doi:10.1097/AOG.0000000000001051.
PMID: 26287791 - 2
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.
Mackie FL, Hemming K, Allen S, et al.
BJOG : an international journal of obstetrics and gynaecology 2017; (124(1)):32-46 doi:10.1111/1471-0528.14050.
PMID: 27245374 - 3
Society for Maternal-Fetal Medicine Consult Series #74: Cell-free DNA screening for aneuploidies: Updated guidance.
, Rink BD, Dugoff L, et al.
Pregnancy (Hoboken, N.J.) 2025; (1(6)):e70139 doi:10.1002/pmf2.70139.
PMID: 42597105 - 4
Predicting fetoplacental mosaicism during cfDNA-based NIPT.
Neofytou M
Current opinion in obstetrics & gynecology 2020; (32(2)):152-158 doi:10.1097/GCO.0000000000000610.
PMID: 31977337 - 5
[Impact of confined placental mosaicism on non-invasive prenatal testing and pregnancy outcomes].
Wu X, Huang H, Chen X, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(4)):335-338 doi:10.3760/cma.j.cn511374-20200803-00574.
PMID: 33834459 - 6
Z-score-based posttest risk as an alternative risk metric to positive predictive value following positive noninvasive prenatal screening.
Gaudet E, Persson F, Saidel M
American journal of obstetrics and gynecology 2025; (232(4)):367-372 doi:10.1016/j.ajog.2024.12.017.
PMID: 39689779 - 7
Cell free DNA testing-interpretation of results using an online calculator.
Grace MR, Hardisty E, Green NS, et al.
American journal of obstetrics and gynecology 2015; (213(1)):30.e1-30.e4 doi:10.1016/j.ajog.2015.05.004.
PMID: 25957020 - 8
Non-invasive prenatal testing for the diagnosis of congenital abnormalities: Insights from a large multicenter study in southern China.
Cai M, Lin N, Chen X, et al.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2023; (56()):e12506 doi:10.1590/1414-431X2023e12506.
PMID: 37377305 - 9
Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age.
Zhu H, Jin X, Xu Y, et al.
BMC pregnancy and childbirth 2021; (21(1)):86 doi:10.1186/s12884-021-03570-6.
PMID: 33499806 - 10
Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
Scott F, Smet ME, Elhindi J, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (62(4)):497-503 doi:10.1002/uog.26272.
PMID: 37247395 - 11
Impact of a detailed ultrasound in pregnancies with high-risk cell-free DNA for common autosomal aneuploidies: a systematic review and meta-analysis.
D'Alberti E, Sorrenti S, Kagan KO, et al.
European journal of obstetrics, gynecology, and reproductive biology 2026; (324()):115258 doi:10.1016/j.ejogrb.2026.115258.
PMID: 42322773 - 12
Invasive Prenatal Diagnostic Testing for Aneuploidies in Singleton Pregnancies: A Comparative Review of Major Guidelines.
Giovannopoulou E, Tsakiridis I, Mamopoulos A, et al.
Medicina (Kaunas, Lithuania) 2022; (58(10)) doi:10.3390/medicina58101472.
PMID: 36295632 - 13
The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure.
Grati FR, Bajaj K, Malvestiti F, et al.
Prenatal diagnosis 2015; (35(10)):994-8 doi:10.1002/pd.4659.
PMID: 26211640 - 14
Fetal Aneuploidy: Screening and Diagnostic Testing.
LeFevre NM, Sundermeyer RL
American family physician 2020; (101(8)):481-488.
PMID: 32293844 - 15
Confined placental mosaicism and its impact on confirmation of NIPT results.
Mardy A, Wapner RJ
American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(2)):118-22 doi:10.1002/ajmg.c.31505.
PMID: 27184347 - 16
Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.
Salomon LJ, Sotiriadis A, Wulff CB, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (54(4)):442-451 doi:10.1002/uog.20353.
PMID: 31124209 - 17
Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study.
Hsu WW, Hsieh CJ, Lee CN, et al.
Journal of the Formosan Medical Association = Taiwan yi zhi 2019; (118(7)):1107-1113 doi:10.1016/j.jfma.2019.03.006.
PMID: 30928186 - 18
Evaluation of Fetal and Maternal Outcomes in Chorion Villus Sampling (CVS).
Movahedi M, Farahbod F, Zarean E, et al.
Advanced biomedical research 2023; (12()):133 doi:10.4103/abr.abr_229_22.
PMID: 37434920 - 19
Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.
Haug S, Goldstein M, Cummins D, et al.
JAMA pediatrics 2017; (171(4)):382-387 doi:10.1001/jamapediatrics.2016.4798.
PMID: 28192554
This page explains what a positive NIPT for trisomy 18 may mean and how confirmatory testing works for educational purposes only; it is not medical advice. Discuss your result, testing options, and pregnancy decisions with your obstetric clinician, genetic counselor, or maternal-fetal medicine specialist.